ArticleScientific reports2025
Differentiation between patent foramen ovale and pulmonary arteriovenous malformations via simultaneous contrast transthoracic echocardiography and transcranial doppler.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnosis and Management of Patent Foramen Ovale for Stroke Prevention: An Australian and New Zealand Consensus Statement Developed by a Modified Nominal Group Approach.The Medical journal of Australia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The objective is to differentiate between patent foramen ovale (PFO) and pulmonary arteriovenous malformations (PAVM) using simultaneous contrast transthoracic echocardiography (cTTE) and contrast transcranial cerebral Doppler (cTCD). A total of 193 patients suspected of having a right-to-left shunt were classified into four groups based on the reference standard, including PFO (n = 102), PAVM (n = 18), negative subjects (n = 53), and indeterminate group (n = 20). Simultaneous cTTE and cTCD were performed in all patients. The comparison between PFO and PAVM was as follows: (1) The cut-off for cardiac cycles was set at ≤ 3 for PFO and ≥ 4 for PAVM. (2) Regarding the quantity of left atrial (LA) bubbles at rest, less than 30 bubbles were observed in 76.4% of patients with PFO, while more than 30 bubbles were found in 94.4% of patients with PAVM. (3) The cut-off of incremental bubbles during modified Valsalva were set at ≥ 10 bubbles for PFO and ≤ 1 bubble for PAVM. (4) The percentages of observed bubbles crossing either interatrial septum or pulmonary vein were 11.8% and 72.2% in the PFO and PAVM groups, respectively. In PFO group, the simultaneous use of cTTE and cTCD demonstrated a high area under the curve (AUC) of 0.973 using incremental bubbles. The successful application of cTCD-guide Valsalva maneuver resulted in a higher quantity of LA bubbles observed in cTTE findings. Simultaneous use of cTTE and cTCD enables differential diagnosis between PFO and PAVM. Moreover, the use of cTCD-guide Valsalva maneuver is recommended for PFO diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.